Syndax Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
SNDX Nasdaq 2834 syndax.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Sep 4th, 2026 2:01 pm
Syndax Announces Participation in September Investor Conferences - Sep 1st, 2026 5:00 am
Citi Predicts Up to 410% Rally for These 2 ‘Strong Buy’ Stocks - Aug 22nd, 2026 12:05 pm
Syndax (SNDX) Sales Nearly Doubled, So Why Did The Stock Fall? - Aug 12th, 2026 3:35 pm
Syndax (SNDX) Q2 2026 Earnings Call Transcript - Aug 11th, 2026 8:45 pm
How Surging Revuforj and Niktimvo Sales and Narrowing Losses Could Shape Syndax Pharmaceuticals (SNDX) Investors - Aug 7th, 2026 8:18 am
Syndax Pharmaceuticals Inc (SNDX) (Q2 2026) Earnings Call Highlights: Revenue Surges 92% as ... - Aug 4th, 2026 11:04 pm
Syndax Pharmaceuticals Q2 Earnings Call Highlights - Aug 4th, 2026 9:03 pm
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Lags Revenue Estimates - Aug 4th, 2026 3:15 pm
Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update - Aug 4th, 2026 2:01 pm
Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026 - Jul 28th, 2026 5:00 am
Harmony Biosciences (HRMY) Soars 10.0%: Is Further Upside Left in the Stock? - Jul 22nd, 2026 5:58 am
Syndax Pharmaceuticals (SNDX) Is Up 8.20% in One Week: What You Should Know - Jul 17th, 2026 10:00 am
Syndax Pharmaceuticals Maps Growth Beyond Revuforj With Lung Cancer, Myelofibrosis Push - Jul 14th, 2026 2:02 pm
Wall Street Analysts Think Syndax (SNDX) Could Surge 70.38%: Read This Before Placing a Bet - Jul 14th, 2026 7:55 am
Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event - Jul 14th, 2026 6:00 am
Is Syndax Pharmaceuticals, Inc. (SNDX) Stock Still a Biotech Opportunity After Revised AML Market Estimates? - Jun 30th, 2026 7:06 am